Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epigenome-wide DNA Methylation Profiling in Aneurysmal Subarachnoid Hemorrhage and Delayed Ischemic Neurologic Deficit

NCT06881329 is registered in ClinicalTrials.gov with Pomeranian Medical University Szczecin as lead sponsor.

NCT NCT06881329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06881329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epigenome-wide DNA Methylation Profiling in Aneurysmal Subarachnoid Hemorrhage and Delayed Ischemic Neurologic Deficit
Lead sponsor
Pomeranian Medical University Szczecin
Phase
Observational
Overall status
Active, not recruiting
Start date
December 20, 2021
Completion date
December 31, 2025
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral vasospasm after subarachnoid hemorrhage, delayed cerebral ischemia, intracranial aneurysm, subarachnoid hemorrhage, aneurysmal